Question.5202 - For this week's assignment, please answer the questions on the linked Assignment 2. The materials provided for this week's lesson are sufficient for answering the questions. There is no need to use external sources. Please answer the questions in one coherent narrative of a 200-word essay submitted in a Word document. Your name and the date must be atop the document. Using appropriate medical terminology, this hypothetical patient’s case study accurately documents the patient's medical history, symptoms, and diagnosis.
Answer Below:
Case xxxxx on xx Brown xxxxxxxxxxx my xxxxxxxxxxxxx from xxx course xxxxxxx firstly xx terms xx Brown's xxxxxxxxxx symptoms xxx dyspnea xx exertion xxxxxxxxxxx fatigue xxx also xxxxxxxxx lower xxxxxxxxx pitting xxxxx hallmarks xx decompensated xxxxxxxxxx heart xxxxxxx Dyspnea xx secondary xx pulmonary xxxxxx hypertension xxx interstitial xxxxx accumulation xxxxxxx reduced xxxx compliance xxxxx fatigue xxxxxxxx impaired xxxxxxxxx and xxxxxxx oxygen xxxxxxxx to xxxxxxxxxx tissues xxx to xxxxxxxxx cardiac xxxxxx and xxx peripheral xxxxx is xxxxxxxxxx to xxxxxxxxx systemic xxxxxx pressures xxx renal xxxxxxxxxxxx mechanisms xxxxxxxxxx the xxxxxxxxxxxxxxxxxxxxxxxxxxxxx system xxxx leading xx sodium xxx fluid xxxxxxxxx Mr xxxxxxx signs xx heart xxxxxxxxxxxxxxx considering xxx case xxxxx on xxxxxxxx examination xxxxxxx Mr xxxxx demonstrates xxxxxxxx hypertension xxxxxxxxxxx and xxxxxxxxxxxx breath xxxxxx particularly xxxxxxx crackles xx rales xxxxxxxxxx pulmonary xxxxxxxxxx While xxxxxxx venous xxxxxxxxxx and xxxxxxxxxxxx may xxxx be xxxxxxx the xxxxxxxxxxxxxxxxx finding xx an xxxxxxxx fraction xx classifies xxx condition xx heart xxxxxxx with xxxxxxx ejection xxxxxxxx consistent xxxx systolic xxxxxxxxxxx Additional xxxxxxxx may xxxxxxx S xxxxxx cool xxxxxxxxxxx and xxxxxxxxx indicating xxxxxx overload xxx poor xxxxxxx flow xx Brown's xxxx medical xxxxxxxxxxxx on xx understanding xxxxxxx document xxxxxxx includes xxxxxxxxx hypertension xxxx I xxxxxxxxxxxxxxxxxxxx E xxx long-term xxxxxxx use xxxxxxxx dependence x all xx which xxx significant xxxx factors xxx the xxxxxxxxxxx of xxxxxxxxxxxxxxx ischemic xxxxxxxxxxxxxx and xxxxxxxxxx systolic xxxxx failure x believe xxxxxxx chronic xxxxxxxxxxxxxx with xxxxxxxxxx antihypertensives xxx lipid xxxxxxxx agents xxxxx have xxxxxxxxxxx left xxxxxxxxxxx remodeling xxxxxxxx and xxxxxxxxxx dysfunction xxxx exposed xx such xxxxxx cardiovascular xxxx - xx defined xx the xxxxxxxxxx Risk xxxxx and xxx AHA xxxxxxxxxx Mr xxxxx has xxxxx gone x transthoracic xxxxxxxxxxxxxxxx - xxxx quantified xxx left xxxxxxxxxxx ejection xxxxxxxx at x diagnostic xxxxxxxxx for xxxxx Additional xxxxxxxxxx workup xxx include xxxxxx natriuretic xxxxxxx or xxxxxxxxx levels xxxx are xxxxxxxx in xxxxxxxxxx wall xxxxxx Based xx my xxxxxxxxxxxxx a xxxxx radiograph xxxxx likely xxxx cardiomegaly xxx pulmonary xxxxxxxx congestion xxx lastly xxxxxxxxxxxxxxxxx reveals xxxxxxxx of xxxx ventricular xx ischemic xxxxxxxx is xxxxxxxxx The xxxxxxxxxx diagnosis xx Mr xxxxx s xxxxxxxxxxxx on xxxxxxxx presentation xxxxxxx and xxxxxxxxxxxxxxxxx findings xx Brown xx definitively xxxxxxxxx with xxxxxxxx heart xxxxxxx categorized xxxxx heart xxxxxxx with xxxxxxx ejection xxxxxxxx which xxxxx on xx understanding xx characterized xx impaired xxxxxxxxxx contractility xxx an xx The xxxxxxxxxxxxxxx involves xxxxxxxxxxx dilation xxxxxxxxxxxxx activation xxxxxxxxx RAAS xxx sympathetic xxxxxxx system xxx progressive xxxxxxxxxx remodeling xxxxx on xxx observation xxx diagnosis xxxxx to xxxxx with xxx American xxxxxxx of xxxxxxxxxx Stage x and xxxx Class xxxxxx depending xx symptom xxxxxxxx Treatment xxxxxxx for xx Brown xxxxxxxx a xxxxxxxxxxxxxxxxxxx TreatmentMr xxxxx is xxxxxxxxxx to xxxxxx to xxxxxx sodium x day xxx fluid x day xxxxxxxxxxxx to xxxxxx preload xxx also xxxxxxx cessation xx critical xxx to xxx vasoconstrictive xxx pro-inflammatory xxxxxxx Moderate xxxxxxx physical xxxxxxxx that xx around xxxxxxx of xxxxxxx days xxx week xx recommended xx improve xxxxxxxxxxx function xxx exercise xxxxxxxxx guided xx cardiac xxxxxxxxxxxxxx protocols xxxxxx monitoring xxxxx vitals xxx education xx early xxxxx of xxxxxxxxxxxxxx for xxxxxxx experiencing x sudden xxxxx in xxxxxx dyspnea xxx emphasized x Pharmacological xxxx TreatmentBrown's xxxxxxxxxxxxxxx tends xx include xx ACE xxxxxxxxx for xxxxxxx lisinopril xx inhibit xxxxxxxxxxx II-mediated xxxxxxxxxxxxxxxx while xxxxxxxx afterload xxx beta-blocker xxxxxxx like xxxxxxxxxx to xxxxxxxxx sympathetic xxxxxxxxx alongside x loop xxxxxxxx for xxxxxxx furosemide xx terms xx managing xxxxxx overload xxxxxxxxx on xxxxx function xxx potassium xxxxxx an xxxxxxxxxxx antagonist xxx example xxxxxxxxxxxxxx could xx initiated xxxxxx is xxxxxxxx to xxxxxxxxx directed xxxxxxx therapy xxxxxx per xxx AHA xxx guidelines xxxxxxx lab xxxxxxxxxx including xxxxx function xxxxxxxxxxxx and xxx levels xxx prognosis xxx Mr xxxxx a xxxxxxxxx improves xxxx With xxxxxxxxx adherence xx guideline xxxxxxxx therapy xxxxxxxxx modifications xxx close xxxxxx up xx Brown x prognosis xxxxx improve xxx also xxxxxxxxxxxxx interventions xxx attenuate xxxxxxxxxxx remodeling xxxxxxxx hospitalizations xxx improving xxxxxxxxx to xxxxxxxx Long-term xxxxxxxx hinge xx medication xxxxxxxxxx control xx comorbidities xxx absence xx recurrent xxxxxxxxxxxxxxx although xxx is x progressive xxxxxxx systolic xxxxxxxx can xxxxxxx recovered xx in xxxx patients xxxx optimal xxxxxxx particularly xx myocardial xxxxxx is xxx extensive xx ischemic xxxxxx is xxxxxxxxx ReferencesCohen x J xxxxx S x Medical xxxxxxxxxxx An xxxxxxxxxxx Guide xx Illustrated xxxxx Jones xxxxxxxx LearningMore Articles From Medical terminology
.ico)
.ico)
.ico)
